Jacob Zhurinsky
Weizmann Institute of Science
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jacob Zhurinsky.
Journal of Clinical Investigation | 2002
Maralice Conacci-Sorrell; Jacob Zhurinsky; Avri Ben-Ze’ev
The adhesion of cells to their neighbors determines cellular and tissue morphogenesis and regulates major cellular processes including motility, growth, differentiation, and survival. Cell-cell adherens junctions (AJs), the most common (indeed, essentially ubiquitous) type of intercellular adhesions, are important for maintaining tissue architecture and cell polarity and can limit cell movement and proliferation. AJs assemble via homophilic interactions between the extracellular domains of calcium-dependent cadherin receptors on the surface of neighboring cells. The cytoplasmic domains of cadherins bind to the submembranal plaque proteins β-catenin or plakoglobin (γ-catenin), which are linked to the actin cytoskeleton via α-catenin (Figure (Figure1;1; refs. 1, 2). The transmembrane assembly of cadherin receptors with the cytoskeleton is necessary for the stabilization of cell-cell adhesions and normal cell physiology. Figure 1 The dual role of β-catenin in cell adhesion and transcriptional activation. β-Catenin (β) and plakoglobin (Pg) bind to cadherin adhesion receptors, and via α-catenin (α) they associate with the actin cytoskeleton ... Malignant transformation is often characterized by major changes in the organization of the cytoskeleton, decreased adhesion, and aberrant adhesion-mediated signaling. Disruption of normal cell-cell adhesion in transformed cells may contribute to tumor cells’ enhanced migration and proliferation, leading to invasion and metastasis. This disruption can be achieved by downregulating the expression of cadherin or catenin family members or by activation of signaling pathways that prevent the assembly of AJs. The importance of the major epithelial cell cadherin, E-cadherin (E-cad, the product of the CDH1 gene), in the maintenance of normal cell architecture and behavior is underscored by the observation that hereditary predisposition to gastric cancer results from germline mutations in CDH1. Loss of E-cad expression eliminates AJ formation and is associated with the transition from adenoma to carcinoma and acquisition of metastatic capacity (3). Re-establishment of AJs in cancer cells by restoration of cadherin expression (4) exerts tumor-suppressive effects, including decreased proliferation and motility. In this Perspective, we discuss the molecular mechanisms underlying the role of the cadherin-catenin system in the regulation of cell proliferation, invasion, and intracellular signaling during cancer progression.
Journal of Biological Chemistry | 2000
Mark D'Amico; James Hulit; Derek F. Amanatullah; Brian T. Zafonte; Chris Albanese; Boumediene Bouzahzah; Maofu Fu; Leonard H. Augenlicht; Lawrence A. Donehower; Ken-Ichi Takemaru; Randall T. Moon; Roger J. Davis; Michael P. Lisanti; Michael Shtutman; Jacob Zhurinsky; Avri Ben-ze'ev; Armelle Troussard; Shoukat Dedhar; Richard G. Pestell
The cyclin D1 gene encodes the regulatory subunit of a holoenzyme that phosphorylates and inactivates the pRB tumor suppressor protein. Cyclin D1 is overexpressed in 20–30% of human breast tumors and is induced both by oncogenes including those for Ras, Neu, and Src, and by the β-catenin/lymphoid enhancer factor (LEF)/T cell factor (TCF) pathway. The ankyrin repeat containing serine-threonine protein kinase, integrin-linked kinase (ILK), binds to the cytoplasmic domain of β1 and β3integrin subunits and promotes anchorage-independent growth. We show here that ILK overexpression elevates cyclin D1 protein levels and directly induces the cyclin D1 gene in mammary epithelial cells. ILK activation of the cyclin D1 promoter was abolished by point mutation of a cAMP-responsive element-binding protein (CREB)/ATF-2 binding site at nucleotide −54 in the cyclin D1 promoter, and by overexpression of either glycogen synthase kinase-3β (GSK-3β) or dominant negative mutants of CREB or ATF-2. Inhibition of the PI 3-kinase and AKT/protein kinase B, but not of the p38, ERK, or JNK signaling pathways, reduced ILK induction of cyclin D1 expression. ILK induced CREB transactivation and CREB binding to the cyclin D1 promoter CRE. Wnt-1 overexpression in mammary epithelial cells induced cyclin D1 mRNA and targeted overexpression of Wnt-1 in the mammary gland of transgenic mice increased both ILK activity and cyclin D1 levels. We conclude that the cyclin D1 gene is regulated by the Wnt-1 and ILK signaling pathways and that ILK induction of cyclin D1 involves the CREB signaling pathway in mammary epithelial cells.
The EMBO Journal | 1999
Alexander Damalas; Avri Ben-Ze'ev; Inbal Simcha; Michael Shtutman; Juan F.M. Leal; Jacob Zhurinsky; Benjamin Geiger; Moshe Oren
β‐catenin is a multifunctional protein, acting both as a structural component of the cell adhesion machinery and as a transducer of extracellular signals. Deregulated β‐catenin protein expression, due to mutations in the β‐catenin gene itself or in its upstream regulator, the adenomatous polyposis coli (APC) gene, is prevalent in colorectal cancer and in several other tumor types, and attests to the potential oncogenic activity of this protein. Increased expression of β‐catenin is an early event in colorectal carcinogenesis, and is usually followed by a later mutational inactivation of the p53 tumor suppressor. To examine whether these two key steps in carcinogenesis are interrelated, we studied the effect of excess β‐catenin on p53. We report here that overexpression of β‐catenin results in accumulation of p53, apparently through interference with its proteolytic degradation. This effect involves both Mdm2‐dependent and ‐independent p53 degradation pathways, and is accompanied by augmented transcriptional activity of p53 in the affected cells. Increased p53 activity may provide a safeguard against oncogenic deregulation of β‐catenin, and thus impose a pressure for mutational inactivation of p53 during the later stages of tumor progression.
Molecular and Cellular Biology | 2000
Jacob Zhurinsky; Michael Shtutman; Avri Ben-Ze'ev
ABSTRACT β-Catenin and plakoglobin are highly homologous components of cell-cell adherens junctions linking cadherin receptors to the actin cytoskeleton. β-Catenin, in addition, activates transcription by forming a complex with LEF/TCF family transcription factors in the nucleus. Plakoglobin can also bind to LEF-1 and, when overexpressed in mammalian cells, enhances LEF-1-directed transcription. Plakoglobin overexpression, however, results in the elevation and nuclear translocation of endogenous β-catenin. We show here, by DNA mobility shift analysis, that the formation of a plakoglobin-LEF/TCF-DNA complex in vitro is very inefficient compared to a complex containing β-catenin-LEF-DNA. Moreover, in plakoglobin-transfected cells plakoglobin-LEF/TCF-DNA complexes were not formed; rather, the endogenous β-catenin, whose level is elevated by plakoglobin transfection, formed a β-catenin–LEF–DNA complex. Removal of the N- and C-terminal domains of both β-catenin and plakoglobin (leaving the armadillo repeat domain intact) induced plakoglobin-LEF-DNA complex formation and also enhanced β-catenin–LEF–DNA complexing, both with in vitro-translated components and in transfected cells. Transfection with these truncated catenins increased endogenous β-catenin levels, but the truncated catenins acted as dominant-negative inhibitors of β-catenin-driven transcription by forming transcriptionally inactive complexes with LEF-1. When these catenin mutants were prevented from entering the nucleus, by their fusion to the connexin transmembrane domain, they indirectly activated transcription by increasing endogenous β-catenin levels. These results suggest that overexpression of plakoglobin does not directly activate transcription and that formation of catenin-LEF-DNA complexes is negatively regulated by the catenin N- and C-terminal domains.
Proceedings of the National Academy of Sciences of the United States of America | 1999
Michael Shtutman; Jacob Zhurinsky; Inbal Simcha; Chris Albanese; D'Amico M; Richard G. Pestell; Avri Ben-Ze'ev
Journal of Cell Science | 2000
Jacob Zhurinsky; Michael Shtutman; Avri Ben-Ze'ev
Journal of Cell Biology | 1998
Inbal Simcha; Michael Shtutman; Daniela Salomon; Jacob Zhurinsky; Einat Sadot; Benjamin Geiger; Avri Ben-Ze'ev
Journal of Biological Chemistry | 2000
James Hulit; Tal Bash; Maofu Fu; Ferruccio Galbiati; Chris Albanese; Daniel Sage; Amnon Schlegel; Jacob Zhurinsky; Michael Shtutman; Avri Ben-Ze'ev; Michael P. Lisanti; Richard G. Pestell
Journal of Cell Science | 2002
Einat Sadot; Maralice Conacci-Sorrell; Jacob Zhurinsky; Dalia Shnizer; Zeev Lando; Dorit Zharhary; Zvi Kam; Avri Ben-Ze'ev; Benjamin Geiger
Experimental Cell Research | 2000
Avri Ben-Ze'ev; Michael Shtutman; Jacob Zhurinsky